Dr. Schwartz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8042 wurzbach suite 420
San Antonio, TX 78229Phone+1 210-949-0807
Education & Training
- Rush University Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1976 - 1977
- Michael Reese Hospital and Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1975 - 1976
- Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1972 - 1975
- University of Illinois College of MedicineClass of 1972
Certifications & Licensure
- CA State Medical License 1977 - Present
- IL State Medical License 1973 - Present
- TX State Medical License 1977 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients Start of enrollment: 2005 Nov 01
- The Effect of Betahistine on Body Weight in Obese Subjects Start of enrollment: 2007 Jan 01
- Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes Start of enrollment: 2006 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 150 citationsAccuracy of the 5-day freestyle navigator continuous glucose monitoring system : Comparison with frequent laboratory reference measurementsRichard L. Weinstein, Sherwyn Schwartz, Ronald L. Brazg, Jolyon Robert Bugler, Thomas A. Peyser
Diabetes Care. 2007-05-01 - 156 citationsResults of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydroc...Franklin J. Zieve, Marcia F. Kalin, Sherwyn Schwartz, Michael R. Jones, William L. Bailey
Clinical Therapeutics. 2007-01-01 - 167 citationsSafety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trialSherwyn Schwartz, Mila Etropolski, D.Y. Shapiro, Akiko Okamoto, Robert Lange
Current Medical Research and Opinion. 2010-12-17
Press Mentions
- How a New COVID Vaccine Type Could Eliminate the Need for BoostersNovember 22nd, 2022
- More San Antonio Hispanics Need to Participate in Coronavirus Vaccine Trials, Officials UrgeDecember 6th, 2020
- Effect of Alendronate and MK-677 (A Growth Hormone Secretagogue), Individually and in Combination, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic WomenJuly 22nd, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: